Immunogenicity of iron-regulated outer membrane proteins of Pasteurella multocida B:2 in mice model

Subhash Kharb1, Shiv Charan

  • 1Department of Veterinary Microbiology, CCS Haryana Agricultural University, Hisar 125 004, India.

Insights

Iron-regulated outer membrane proteins (IROMP) from Pasteurella multocida B:2 show promise as immunogens. Immunization with IROMP and outer membrane proteins (OMP) induced significant antibody responses and protection against infection in mice.

Area of Science:

  • Veterinary Microbiology
  • Immunology
  • Bacterial Pathogenesis

Background:

  • Pasteurella multocida B:2 is a significant pathogen causing severe infections in animals.
  • Outer membrane proteins (OMP) are crucial for bacterial-host interactions and are potential vaccine candidates.
  • Iron-regulated outer membrane proteins (IROMP) may play a key role in P. multocida virulence and immune evasion.

Purpose of the Study:

  • To evaluate the immunogenicity and protective efficacy of P. multocida B:2 iron-regulated outer membrane proteins (IROMP) in a mouse model.
  • To compare the immune response and protection elicited by IROMP and non-regulated OMP.

Main Methods:

  • Extraction and characterization of outer membrane proteins (OMP) and iron-regulated outer membrane proteins (IROMP) from P. multocida B:2 using SDS-PAGE.
  • Immunization of mice with OMP, IROMP-enriched fractions, and whole cell lysate (WCL).
  • Measurement of antibody titers and assessment of protection against P. multocida challenge via intranasal and subcutaneous routes.

Main Results:

  • Both OMP and IROMP immunization induced significant antibody responses in mice, with IROMP eliciting higher titers.
  • Mice immunized with IROMP and OMP showed 100% protection against intranasal challenge and 84% protection against subcutaneous challenge.
  • Control mice exhibited high mortality (84%) following challenge, highlighting the efficacy of the OMP and IROMP vaccines.

Conclusions:

  • Iron-regulated outer membrane proteins (IROMP) of P. multocida B:2 are potent immunogens.
  • OMP, particularly those enriched with IROMP, represent a promising strategy for developing effective vaccines against P. multocida infections.

Related Concept Videos